Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Parkinson Disease · Parkinson's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Severance Hospital, Seoul, South Korea
Contact: Study coordinator (Professor, MD, PhD) · phlee@yuhs.ac

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neurologic Stem Cell Treatment Study

Neurologic Disorders · Nervous System Diseases · Neurodegenerative Diseases

Abroad (travel likely)Recruiting

Westport, United States · Coral Springs, United States

NYSCF Scientific Discovery Biobank

ALS · Amyotrophic Lateral Sclerosis · Alzheimer Disease

Abroad (travel likely)Recruiting

New York, United States

[18F]ACI-15916 PET in α-synucleinopathies

Parkinson's Disease (PD) · Multiple System Atrophy (MSA) · Dementia With Lewy Bodies (DLB)

Abroad (travel likely)RecruitingEARLY_PHASE1

Solna, Sweden

Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome

Parkinson Disease · Parkinson Disease, Secondary

Abroad (travel likely)Recruiting

Guangzhou, China